Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Onicx Group Announces First Medical Outpatient Building Acquisition of 2025
Onicx Group, based in Tampa. Florida, announced that it acquired a medical outpatient building (MOB) located in King of Prussia, Pennsylvania. The Merion Building is a 71,800-square-foot Class A MOB. The asset is currently 75% leased and features a strong synergistic tenant roster serving a range of outpatient medical specialties. Onicx Group is a prominent developer and a trusted real estate partner for health systems and physician practices, with a longstanding focus on healthcare real estate. The company was founded in 2004. This transaction represents the third asset to be acquired within the last six months by Onicx, and its first in 2025. Onicx has additional... Read More »
HREA Closes Sale of Overland Park, Kansas Medical Outpatient Building Portfolio
HREA | Healthcare Real Estate Advisors (HREA), based in Raleigh, North Carolina, reported on April 14 that it closed on the sale of an Overland Park, Kansas medical outpatient building (MOB) portfolio. Neither the buyer nor the financial terms were disclosed. The MOB consists of three single-tenant buildings that are 100% leased and occupied by College Park Family Care, a multi-specialty group that is a part of HCA Healthcare. HCA operates 186 hospitals and approximately 2,400 sites of care in 20 states and the United Kingdom. According to data captured in the LevinPro HC database, this transaction marks the 58th MOB deal of 2025, and the first reported in Kansas.... Read More »
BayPine Buys Utah-Based CenExel Clinical Research
BayPine LP announced on April 14 that it has entered into a definitive agreement to acquire CenExel Clinical Research, Inc. in Salt Lake City, Utah. Following the closing of the transaction, BayPine will be the majority investor in CenExel alongside previous private equity investor Webster Equity Partners, which will retain a minority stake, as well as CenExel management. CenExel Clinical Research provides medical and scientific support in the design and execution of clinical trials. Formed in 2018, CenExel works with trial sponsors and contract research organizations to reduce costs and development times for therapies. BayPine is a private investment firm that drives innovation, digital... Read More »
PharmaLogic Acquires Agilera
On April 4, PharmaLogic, a portfolio company of Webster Capital and MedEquity Capital, announced that it acquired Agilera Pharma AS. The seller was Insitute for Energy Technology (IFE), a Norwegian company that conducts research on nuclear energy. Agilera Pharma AS was established as a subsidiary of IFE in 2023. Agilera is a contract development manufacturing organization (CDMO) and a contract research organization. It is based in Norway. PharmaLogic operates 15 nuclear pharmacies in the northeast and western United States, serving more than 200 hospitals and medical clinics. It is a leading CDMO specializing in novel diagnostic imaging and therapeutic radiopharmaceuticals for... Read More »
